Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

RedHill Biopharma (RDHL) Return on Assets (2016 - 2024)

RedHill Biopharma has reported Return on Assets over the past 12 years, most recently at 0.03% for Q4 2024.

  • Quarterly Return on Assets rose 4.0% to 0.03% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 0.03% through Dec 2024, up 4.0% year-over-year, with the annual reading at 0.0% for FY2025, 1.0% up from the prior year.
  • Return on Assets was 0.03% for Q4 2024 at RedHill Biopharma, up from 0.02% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.03% in Q4 2024 and troughed at 0.01% in Q3 2022.
  • The 5-year median for Return on Assets is 0.0% (2021), against an average of 0.0%.
  • Year-over-year, Return on Assets decreased -1bps in 2020 and then grew 4bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.0% in 2020, then crashed by -283bps to 0.01% in 2021, then increased by 15bps to 0.0% in 2022, then tumbled by -41bps to 0.01% in 2023, then soared by 561bps to 0.03% in 2024.
  • Per Business Quant, the three most recent readings for RDHL's Return on Assets are 0.03% (Q4 2024), 0.02% (Q2 2024), and 0.01% (Q4 2023).